Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

equity securities

5 posts
UUBS
Buy 3 UBS Global Mutual Funds for a Diversified Portfolio
Read More

Buy 3 UBS Global Mutual Funds for a Diversified Portfolio

  • 2026-07-02
UBS Global mutual funds are offered by UBS Asset Management, the asset management branch of the global firm…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Roche Annual General Meeting 2026

  • 2026-04-09
F. Hoffmann-La Roche Ltd Shareholders approved all proposals of the Board of Directors  Severin Schwan re-elected as Chairman…
RRoche
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
Read More

Roche Annual General Meeting 2026

  • 2026-03-10
F. Hoffmann-La Roche Ltd Shareholders approved all proposals of the Board of Directors  Severin Schwan re-elected as Chairman…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

  • 2026-02-19
F. Hoffmann-La Roche Ltd Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

  • 2026-02-16
F. Hoffmann-La Roche Ltd Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the…
Switzerland
www.europesays.com